跳至主要内容
临床试验/NL-OMON51361
NL-OMON51361尚未招募不适用

Calcium Reduction by Orbital Atherectomy in Western Europe: the CROWN study - CROW

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. De novo significant native coronary artery lesion.
  • 2. The target lesion must have evidence of severe calcification:
  • a. Presence of radiopacities noted without cardiac motion prior to contrast
  • injection involving both sides of the arterial wall with calcification length
  • of at least 15 mm and extend partially into the target lesion.
  • b. Presence of >=270° of calcium or lumen protruding calcified nodule(s) at >1
  • cross section assessed by OCT.
  • 3. The target vessel reference diameter >= 2.5 mm and <= 4.0 mm and lesion must
  • not exceed 40 mm in length.
  • 4. Age > 18 years or minimum age as required by local regulations

排除标准

  • 1. Left main disease
  • 2. Prior stenting of the target vessel.
  • 3. Target lesion has thrombus or dissection.
  • 4. Known LVEF <=25%.
  • 5. Diagnosed with chronic renal failure (GFR<30ml/min)
  • 6. Confirmed pregnancy.
  • 7. Life expectancy <12months.
  • 8. Age<18y.
  • 9. Coronary anatomy that prevent delivery of OCT catheter
  • 10. Known allergy to soybean oil, egg yolk phospholipids, glycerin or sodium

研究者

相似试验